on-Alcoholic Fatty Liver Disease with Newly confirm Diabetes And Its connection With BMI, HBA1c And Standard Lipid Profile and Missed Opportunities for Earlier Diagnosis of Diabetes and NAFLD
- Conditions
- Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
- Registration Number
- CTRI/2022/09/045835
- Lead Sponsor
- Dr Supriyo Mukherjee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Male and female subjects aged 18 years & above.
2. Newly Diagnosed T2DM patients or recently
diagnosed T2DM patients within 6 months of
study participation
3. Availability of complete socio-demographic and
clinical data relevant to the purpose of the
study
4. Subjects willing to provide informed written consent
1. Patients diagnosed with T1DM
2. A record of any amount of liquor consumption
3. Female patients who were pregnant or breast
feeding during the study time period
4. Non-pharmacologically treated diabetes or Past
record of traditional medicine ingestion
5. A past record of acute hepatitis (Hep A, B, C,
Amoebic liver disease) of any cause within 6
months to dismiss any information bias related
to abnormal (Liver function test) LFT findings
6. Chronic Liver Disease or an ongoing history of
Wilson disease, hemochromatosis, autoimmune
hepatitis, and alpha 1- antitrypsin deficiency
7. Malignancy which might involve liver
8. Subjects with any other illness or health
condition which in the opinion/medical
judgement of the study investigator makes the
subject ineligible to participate in the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The prevalence of Non-alcoholic fatty liver disease among newly diagnosed T2DM in North Bihar and its correlation with BMI, HBA1c and standard lipid profile within population of North BiharTimepoint: At baseline
- Secondary Outcome Measures
Name Time Method To determine if there are missed opportunities for earlier diagnosis and understand how Newly diagnosed persons with T2DM develop symptoms of diabetes and NAFLD and clinically presentTimepoint: At Baseline;To determine predictors of NAFLD in newly diagnosed T2DMTimepoint: At Baseline